The least invasive surgical treatment of presbyopia is at the cornea laser treatment with monovision or presbyLASIK and some intracorneal implants have demonstrated good outcomes, although there may be a loss of distance vision. Multifocal intraocular lenses have demonstrated good visual outcomes but require lens or cataract surgery and are implanted in patients aged 50 or 55 years or older when the accommodation is lost completely. Most of the treatments available nowadays to restore spectacle independence for near vision activities are surgical and, hence, invasive either at the level of the cornea, lens, or sclera. ![]() Most importantly, it affects the quality of life as it creates a dependence on glasses to perform near vision activities. Presbyopia is an age-related condition characterized by the progressive loss of accommodation clinically affecting the near vision performance. The group with the youngest patients gained more lines than the group with the oldest patients. ![]() This pharmacological therapy improved near vision by one or more lines (mean improvement 0.18 lines) in 92.3% of the patients at 2 h following the instillation of the eye drops. Fourteen patients (11.9%) reported headaches as a side effect of the therapy. Nine patients did not show an improvement in UNVA, but no patient showed a loss of lines. The mean UNVA before the use of the eye drop was 0.35 LogMAR, which improved to 0.16 LogMAR at 2 h after the use of the eye drop ( p = 0.000). The mean age of the patients was 50.2 years. The patients were divided into two groups according to their age, with group 1 patients being 41 and 50 years old and group 2 patients, between 51 and 65 years old. The objective scatter index and pupil diameter under photopic and scotopic conditions before and after instillation were also assessed. This was a prospective, consecutive, interventional, non-comparative clinical study in which 117 presbyopic patients were given one drop of the novel therapy (FOV tears) in each eye, followed 2 h after the instillation of the eye drop by an evaluation of the binocular uncorrected near visual acuity (UNVA) and uncorrected distance visual acuity. To report the outcomes in near vision, optical quality and pupil diameter of a new pharmacological therapy (FOV tears) for presbyopia.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |